Freezing the tumor is a revolutionary technique for treating breast cancer


WASHINGTON – A first-of-its-kind study indicates that slow-growing breast cancers can be treated with highly targeted tumor freezing technology, eliminating the need for surgery.
It is well known that doctors perform traditional lumpectomy or mastectomy, depending on the disease status of women with cancer and according to the extent of their disease development.
The new research considered that cryoectomy maintains breast size and reduces the risk of infection, and avoids the patient feeling psychological suffering due to the remaining scars and deformities in her body, as it enables her to return to her normal life very quickly.
Experts promise to use the new technology in treating cancers of the bones, kidneys and prostate.
Tests indicate this technique is effective in older women with low-risk breast cancer.
“Cryoablation is a solution that destroys breast tumors safely, quickly and without pain, or the need for surgery,” said study author Dr. Richard Vine, a breast surgeon at the Western Cancer Research Center and Research Institute in Germantown, Tennessee, USA.
“This procedure exposes the diseased tissues to extreme cold to be destroyed in the clinic, without the need for anesthesia,” he added.
The World Health Organization has said that breast cancer has surpassed lung cancer and has become the most common type of malignancy in the world.
“For the first time, breast cancer has become the most common type in the world,” André Elbave, a cancer expert at the World Health Organization, said in a UN press briefing.
He explained that lung cancer has remained the most common over the past two decades, but now it has retreated a step back to second place, ahead of colorectal cancer, which is the third on the list.
Elpavy noted that female obesity is a common risk factor for breast cancer, adding that obesity is a driving factor for overall cancer numbers in the direction of an increase.
He added that as the world’s population grows and life expectancy increases, there is speculation that cancer will become more common, with numbers reaching about 30 million new cases annually by 2040, up from 19.3 million in 2020.
Elbavey said that the Corona pandemic had disrupted cancer treatment efforts in nearly half of the countries studied, and pointed to obstacles including delayed diagnosis, severe stress on health care workers and the current lack of research on cancer.


Please enter your comment!
Please enter your name here